Business Context and Reporting Period
This Form 6-K filing, dated December 10, 2025, reports on Aegon Ltd.'s Capital Markets Day 2025. The company announced a strategic pivot to become a leading US life insurance and retirement group. Aegon plans to relocate its head office and legal seat from Bermuda/Netherlands to the United States, renaming the holding company "Transamerica Inc." upon completion, targeted for January 1, 2028. The filing outlines the transition strategy, financial targets, and a strategic review of its UK operations.
Key Financial Metrics and Capital Actions
- 2025 Performance: Aegon confirmed it is achieving all financial targets for 2025.
- Operating Result (2025 Run-rate): EUR 1.5 - 1.7 billion.
- Operating Cash Generation (OCG) (2025 Run-rate): Approximately EUR 0.9 billion.
- Free Cash Flow (2025 Run-rate): Approximately EUR 0.8 billion per year.
- Dividend: Approximately EUR 0.40 per share for 2025, with a target growth of >5% per annum.
- Share Buyback: A new EUR 400 million program announced, split evenly between H1 and H2 2026.
- Capital Employed (Financial Assets): Reduced by USD 0.3 billion to USD 2.7 billion following a reinsurance transaction; target of USD 2.2 billion by year-end 2027.
- Cash Capital at Holding: Maintained around the mid-point of the EUR 0.5 to 1.5 billion operating range.
Material Changes and Strategic Transactions
- Re-domiciliation: Aegon will move its legal seat to the US, aiming to report under US GAAP starting with full-year 2027 results. Trading updates will cease in 2026 and 2027, replaced by comprehensive half-year reporting.
- SGUL Reinsurance: Aegon reinsured 30% of its Secondary Guarantee Universal Life (SGUL) block (USD 10 billion net face value). This reduces capital employed by USD 0.3 billion and removes mortality/behavioral risks.
- Capital Investment: A USD 800 million investment into Transamerica was made to neutralize the negative RBC ratio impact of the reinsurance transaction, enabling an additional USD 75 million in annual remittances.
- Implementation Costs: Estimated one-time costs of EUR 350 million for the relocation, to be incurred between 2H 2025 and 1H 2028.
- UK Strategic Review: Aegon initiated a review of Aegon UK to evaluate all options, including potential divestment, to maximize value.
Guidance, Outlook, and Management Commentary
Management projects the following growth rates between 2025 and 2027:
- Operating Result: Growth of ~5% per annum.
- OCG: Growth of 0% to 5% per annum.
- Free Cash Flow: Growth of ~5% per annum.
- Dividend Per Share: Growth in excess of 5% per annum, supported by share buybacks.
Business Unit Targets (2027):
- Transamerica (US): World Financial Group (WFG) life sales to reach ~USD 900 million; annuity sales to reach ~USD 5.0 billion. Retirement plan Assets under Administration (AuA) to reach ~USD 275 billion.
- Aegon Asset Management: Operating result target of >EUR 200 million; Global Platforms operating margin target of at least 20%.
Risks and Contingencies: The filing highlights significant risks including the uncertainty of completing the US relocation, regulatory approvals, integration challenges, and potential impacts on the Dutch supervisory board of a.s.r. (Aegon's largest shareholder). Forward-looking statements are subject to market volatility, interest rate changes, and geopolitical instability.
Investor Verification Checklist
- Verify the timeline and regulatory approval status for the re-domiciliation to the US and the name change to Transamerica Inc.
- Confirm the execution of the EUR 400 million share buyback program starting January 2026.
- Monitor the outcome of the strategic review of Aegon UK, specifically regarding potential divestment.
- Track the reduction of capital employed in US Financial Assets toward the USD 2.2 billion 2027 target.
- Assess the impact of the EUR 350 million one-time implementation costs on interim earnings between 2025 and 2028.
- Review the transition from IFRS to US GAAP reporting beginning in 2027 and the cessation of quarterly trading updates.